727
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A five-gene qPCR signature can classify type 2 asthma comparably to microscopy of induced sputum from severe asthma patients

, , , & ORCID Icon
Article: 2293318 | Received 14 Aug 2023, Accepted 06 Dec 2023, Published online: 21 Dec 2023

References

  • Soriano JB. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lan Respi Med. 2020;8(6):585–8.
  • Asthma GIF. Global Initiative for asthma. Global Strategy Asthma Management Prevention. 2022;2022.
  • Williams SA, Wagner S, Kannan H, et al. The association between asthma control and health care utilization, work productivity loss and Health-related quality of life. J Occup Environ Med. 2009;51(7):780–785. doi: 10.1097/JOM.0b013e3181abb019
  • Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci. 2017;131(13):1541–1558. doi: 10.1042/CS20160487
  • Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360(9347):1715–1721. doi: 10.1016/S0140-6736(02)11679-5
  • Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360(10):973–984. doi: 10.1056/NEJMoa0808991
  • Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455–2466. doi: 10.1056/NEJMoa1304048
  • Winter NA, Qin L, Gibson PG, et al. Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma. J Allergy Clin Immunol. 2021;148(2):428–438. doi: 10.1016/j.jaci.2021.01.033
  • Baines KJ, Simpson JL, Wood LG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997–1007. doi: 10.1016/j.jaci.2013.12.1091
  • Fricker M, Gibson PG, Powell H, et al. A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma. J Allergy Clin Immunol. 2019;144(1):51–60.e11. doi: 10.1016/j.jaci.2018.12.1020
  • Fricker M, Qin L, Niessen N, et al. Relationship of sputum mast cells with clinical and inflammatory characteristics of asthma. Clin Exp Allergy. 2020;50(6):696–707. doi: 10.1111/cea.13609
  • Jiang J, Faiz A, Berg M, et al. Gene signatures from scRNA-seq accurately quantify mast cells in biopsies in asthma. Clin Exp Allergy. 2020;50(12):1428–1431. doi: 10.1111/cea.13732
  • Li Y, Gao J, Kamran M, et al. GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super-enhancers. Nat Commun. 2021;12(1):494. doi: 10.1038/s41467-020-20766-0
  • Dougherty RH, Sidhu SS, Raman K, et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol. 2010;125(5):1046–1053.e8. doi: 10.1016/j.jaci.2010.03.003
  • Wang G, Baines KJ, Fu JJ, et al. Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma. Eur Respir J. 2016;47(4):1123–1133. doi: 10.1183/13993003.01098-2015
  • Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007;104(40):15858–15863. doi: 10.1073/pnas.0707413104
  • Kuo C-HS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J. 2017;49(2):1602135. doi: 10.1183/13993003.02135-2016
  • Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2015;80(3):372–380. doi: 10.1111/bcp.12637
  • Raissy HH, Kelly HW, Harkins M, et al. Inhaled corticosteroids in lung diseases. Am J Respir Crit Care Med. 2013;187(8):798–803. doi: 10.1164/rccm.201210-1853PP
  • Paggiaro PL, Holz O, Ind PW, et al. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s. doi: 10.1183/09031936.02.00000302
  • Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;89(10):3636–43. doi: 10.1182/blood.V89.10.3636
  • Maaninka K, Lappalainen J, Kovanen PT. Human mast cells arise from a common circulating progenitor. J Allergy Clin Immunol. 2013;132(2):463–9.e3. doi: 10.1016/j.jaci.2013.02.011
  • Hirasawa N. Expression of Histidine decarboxylase and its roles in inflammation. Int J Mol Sci. 2019;20(2):20. doi: 10.3390/ijms20020376
  • Kraft S, Rana S, Jouvin M-H, et al. The Role of the FcεRI β-chain in allergic diseases. Int Arch Allergy Immunol. 2004;135(1):62–72. doi: 10.1159/000080231
  • Rijavec M, Krumpestar T, Škrgat S, et al. T2-high asthma, classified by sputum mRNA expression of IL4, IL5, and IL13, is characterized by Eosinophilia and severe phenotype. Life (Basel). 2021;11(2):92. doi: 10.3390/life11020092
  • Berthon BS, Gibson PG, Wood LG, et al. A sputum gene expression signature predicts oral corticosteroid response in asthma. Eur Respir J. 2017;49(6):1700180. doi: 10.1183/13993003.00180-2017